UTHR News and Press, United Therapeutics Corporation From 03/28/24

2024-03-28 16:24:45 ET Read the full article on Seeking Alpha For further details see: Liquidia gains after court win in patent dispute with United Therapeutics

2024-03-27 09:50:45 ET More on Merck Merck & Co., Inc. (MRK) Presents at Barclays 26th Annual Global Healthcare Conference (Transcript) Merck & Co., Inc. (MRK) Management presents at Leerink Partners 2024 Global Biopharma Conference (Transcript) Merck & C...

2024-03-26 17:48:09 ET More on Merck Merck Phase 3 trial for Keytruda combo fails in lung cancer Merck hits main goal for Keytruda in late-stage trial for cervical cancer Merck & Co., Inc. (MRK) Presents at Barclays 26th Annual Global Healthcare Conference (Trans...

2024-03-26 11:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Review manuscript available in the journal Physiological Reviews United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, today announced the online availability of a review manuscript titled “Physiological Basis for Xenotransplantation from Genetically-...

Repurchase reflects the strength of United Therapeutics’ balance sheet and confidence in its near-term prospects United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, today announced that its Board of Directors has authorized the company to purchase u...

2024-03-21 12:56:43 ET More on AstraZeneca, Eledon Pharmaceuticals, etc. What AstraZeneca Is Getting Through The Acquisition Of Fusion Pharmaceuticals 5 Reasons AstraZeneca Stock Can Rise In 2024 AstraZeneca PLC (AZN) Q4 2023 Earnings Call Transcript Merck Ph...

2024-03-20 08:17:55 ET Summary United Therapeutics is a biotech and pharmaceutical company specializing in cardiovascular disorder treatments and organ manufacturing. UTHR's treatments for cardiovascular disorders include PAH, PH-ILD, and pediatric oncology drugs. The company's re...

2024-03-16 09:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-03-05 20:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...